Anti-(Fc Fragment Of Igg Receptor Iib) Monoclonal Antibody Bi-1206

2 trials 2 recruiting NNeurology/Psychiatry

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

5 Countries

Phase I/II

Phase I/II: 2

Sponsors using this IMP

BioInvent International AB 2

All trials

2 total

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcyRIIB), in Combination with Rituximab With or Without Acalabrutinib … Recruiting

2024-512972-36-00 Phase I/II 2 countries BioInvent International AB
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced … Recruiting

2023-509846-36-00 Phase I/II 5 countries BioInvent International AB

Showing 1–2 of 2 trials

← All drugs A–Z